HIP1: trafficking roles and regulation of tumorigenesis

被引：49

作者：

Hyun, TS

Ross, TS ^{[1
]}

机构：

[1] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA

[2] Univ Michigan, Sch Med, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA

来源：

TRENDS IN MOLECULAR MEDICINE | 2004年 / 10卷 / 04期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1016/j.molmed.2004.02.003

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

During recent years, alterations in proteins of the endocytic pathway have been associated with tumors. Disrupted regulation of the endocytic pathway is a relatively unstudied mechanism of tumorigenesis, which can concomitantly disrupt several different signaling pathways to affect growth, differentiation and survival. Several endocytic proteins have been identified, either as part of tumor-associated translocations or to have the ability to transform cells. Here, we summarize the information known about huntingtin interacting protein 1 (HIP1), an endocytic protein with transforming properties that is involved in a cancer-causing translocation and which is overexpressed in a variety of human cancers. We describe the known normal functions of HIM in endocytosis and receptor trafficking, the evidence for its role as an oncoprotein and how HIP1 might be altered to promote tumorigenesis.

引用

页码：194 / 199

页数：6

共 50 条

[1]

Adams A, 2000, J BIOL CHEM, V275, P27414

[2] HIP12 is a non-proapoptotic member of a gene family including HIP1, an interacting protein with huntingtin [J].